S. Vecchio, A. Giampreti, and V. Petrolini, Metformin accumulation: Lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy, Clinical Toxicology, vol.10, issue.2, 2013.
DOI : 10.1111/j.1365-2710.2010.01192.x

J. Lalau, Lactic Acidosis Induced by Metformin, Drug Safety, vol.53, issue.2, pp.727-767, 2010.
DOI : 10.2165/11536790-000000000-00000

N. Peters, N. Jay, and D. Barraud, Metformin-associated lactic acidosis in an intensive care unit, Critical Care, vol.12, issue.6, p.149, 2008.
DOI : 10.1186/cc7137

F. Flavier and N. Moullec, Prevalence of type 2 diabetes and central adiposity in La Reunion Island, the REDIA Study, Diabetes Res Clin Pract, pp.234-276, 2005.

A. Scheen and N. Paquot, Metformin revisited: A critical review of the benefit???risk balance in at-risk patients with type 2 diabetes, Diabetes & Metabolism, vol.39, issue.3, pp.179-90, 2013.
DOI : 10.1016/j.diabet.2013.02.006

J. Lopez and K. Annunziata, Impact of hypoglycemia on patients with type 2 diabetes. Diabeets Metab, pp.179-90, 2013.

J. Cogneau and A. Lehr-drylewicz, Guidelines and pratices for type 2 diabetes. Patients' and doctors' preconceptions prevent effective patient education. Presse Medicale Paris fr 1983, 2007.

L. Zohalan and F. Chawoei, Prevalence of chronic complications of type 2 diabetes mellitus in outpatients-a cross-sectional hospital basedsurvey in urban China

A. Onat and I. Donmez, Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunity, Expert Review of Cardiovascular Therapy, vol.12, issue.6, pp.667-79, 2014.
DOI : 10.1586/14779072.2014.910114

A. Rollo and S. Salardi, Transition from pediatric to adult care. Eight years after the transition from pediatric to adult diabetes care: metabolic control, complications and associated diseases, Journal of Endocrinological Investigation, vol.25, issue.7, 2014.
DOI : 10.1007/s40618-014-0090-9

V. Shivakumar and A. Kandhare, Estimation of the long-term cardiovascular cvents using UKPDS risk engine in metabolic syndrome patients, Indian J Pharm Sci, pp.174-182, 2014.

P. Mcgee and M. Steffes, Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study, Diabetic Medicine, vol.57, issue.10, 2014.
DOI : 10.1111/dme.12504

A. Scheen and B. Charbonnel, Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: A critical reappraisal, Diabetes & Metabolism, vol.40, issue.3, 2014.
DOI : 10.1016/j.diabet.2014.03.004

P. Gillery, What's new about hemoglobin A1C, groupe de travail, standardisation des dosages d'hémoglobine glyquée de la société française de biologie clinique

B. Senez and P. Felicioli, Quality of life assessment of type 2 diabetic patients in general medicine. Presse Medicale Paris Fr 1983, Feb, vol.14, pp.161-167, 2004.

A. Cicero and E. Tartagni, Metformin and its clinical use : new insights for an old drug in clinical practice, Arch Med Sci AMS, pp.907-924, 2009.

M. El-mir and V. Nogueira, Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I, Journal of Biological Chemistry, vol.275, issue.1, pp.223-231, 2000.
DOI : 10.1074/jbc.275.1.223

URL : https://hal.archives-ouvertes.fr/inserm-00390049

W. Huang and R. Castelino, Metformin usage in type 2 diabetes mellitus: are safety guidelines adhered to?, Internal Medicine Journal, vol.28, issue.3, pp.266-72, 2014.
DOI : 10.1111/imj.12369

D. Su and X. Wang, Metformin vs insulin in the management of gestional diabetes : a systematic review and meta-analysis, Diabetes Res Clin Pract, 2014.

S. Malin and S. Kashyap, Effects of metformin on weight loss, Current Opinion in Endocrinology & Diabetes and Obesity, vol.21, issue.5, 2014.
DOI : 10.1097/MED.0000000000000095

R. Holt and K. Lambert, The use of oral hypoglycemic agents in pregnancy, Diabet Med J Br Diabet Assoc, pp.282-91, 2014.

L. Rojas and M. Gomes, Metformin: an old but still the best treatment for type 2 diabetes, Diabetology & Metabolic Syndrome, vol.5, issue.1, p.6, 2013.
DOI : 10.1111/j.1463-1326.2008.00973.x

U. Bergman and G. Boman, Epidemiology of adverse drug reactions to phenformin and metformin., BMJ, vol.2, issue.6135, pp.464-470, 1978.
DOI : 10.1136/bmj.2.6135.464

F. Fourrier and A. Seidowsky, Intoxication par la metformine??: m??canismes de toxicit?? et prise en charge, R??animation, vol.19, issue.6, pp.539-583, 2010.
DOI : 10.1016/j.reaurg.2010.05.011

P. Van-beest and L. Brander, Cumulative lactate and hospital mortality in ICU patients. Ann Intensive Care, pp.7-8

M. Owen and E. Doran, Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain, Biochem J, vol.15, pp.607-621, 2000.

L. Gladden, Lactate metabolism: a new paradigm for the third millennium, The Journal of Physiology, vol.32, issue.suppl., pp.30-35, 2004.
DOI : 10.1113/jphysiol.2003.058701

R. Chiolero and L. Tappy, Effect of Major Hepatectomy on Glucose and Lactate Metabolism, Annals of Surgery, vol.229, issue.4, pp.505-518, 1999.
DOI : 10.1097/00000658-199904000-00009

A. Al-hwiesh and I. Abdul-rahman, Metformin in Peritoneal Dialysis: A Pilot Experience, Peritoneal Dialysis International, vol.34, issue.4, 2014.
DOI : 10.3747/pdi.2013.00048

J. Lalau and M. Andrejak, Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin : a study of metformin elimination. Int I Clin Pharmacol, pp.285-293, 1989.

O. Fourcade and T. Geeraerts, Traité d'anesthésie et de la réanimation, pp.897-896

A. Emslie-smith and D. Boyle, Contraindications to metformin therapy in patients with type 2 diabetes :a population based study of adherence to precribing guidelines, Diabet Med J Br Diabet Assoc, pp.483-491, 2001.

J. Orban and L. D. , Complications métaboliques du diabète, Les Essenciels, pp.480-471, 2006.

J. Lalau and J. Race, Metformin and lactic acidosis in diabetic humans, Diabetes, Obesity and Metabolism, vol.21, issue.3, pp.131-138, 2000.
DOI : 10.1002/(SICI)1096-9136(199701)14:1<19::AID-DIA289>3.0.CO;2-0

J. Lalau and C. Lacroix, Measurement of metformin concentrationin erythrocytes : clinical implications. Diabetes Obes Metab, 2003.

J. Lalau and J. Race, Acidose lactique chez les sujets diabétiques traités par biguanides, pp.501-510, 1998.

F. Kajbaf and J. Lalau, Mortality rated in so-called « metformine associated lactic acidosis » : a review of the data since the 1960s, Pharmacoepidemiol Drug Saf, 2014.

C. Girman and T. Kou, Risk of acute renal failure in patients with Type???2 diabetes mellitus, Diabetic Medicine, vol.46, issue.5, pp.614-635, 2012.
DOI : 10.1111/j.1464-5491.2011.03498.x

K. Lipska and C. Bailey, Use of metformin in the setting of mild to moderate renal insufficiency. Diabetes Care, pp.1431-1438, 2011.

D. Eurich and S. Majumdar, Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care, pp.2345-51, 2005.

J. Ndong and R. , Caractéristiques, risque vasculaire, complications et qualités des soins des personnes diabetiques dans les dpartements d'outre-mer et comparaison à la métropole : Etude ENTRE, 2007.

M. Bodner, C. Meier, and . Metformin, Sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis of hypoglycemia. A nested case-control analysis. Diabetes Care, pp.2086-91, 2008.

J. Lalau and J. Race, Lactic acidosis in metformin-treated pateints. Prognostic value of aretrial lactate levels and plasma metformin concentrations, Drug Saf Int J Med Toxicol Drug Exp, pp.377-84, 1999.

A. Holstein and A. Nahrwold, Contraindications to metformin therapy are largely disregarded, Diabet Med J Br Diabet Assoc, pp.692-698, 1999.

B. Rasouli and T. Andersson, Alcohol and the risk for LADA : results based on the Swedish ESTRID study, Eur J Endocrinol Eur Fed Endocr Soc, 2014.

R. Gerecht, The lethal Triad, Hypothermia, acidosis and coagulopathy create a deadly cycle for trauma patients, JEMS J Emerg Med Serv, 2014.

K. Polderman, Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality : practical aspects and side effects, Intensive Care Med, pp.757-69, 2004.

F. Montini and E. Rondeau, Metformin associates lactic acidosis. Presse Medicale Paris Fr 1983, pp.907-923, 2012.

C. Ichai and J. Guerin, Le lactate en réanimation